Frequently asked questions What are the tirzepatide weight-loss doses
The researchers found that the risk for a primary outcome event (major kidney disease events, a composite of the onset of kidney failure, at least a 50 percent reduction in the estimated glomerular filtration rate from baseline, or death from kidney-related or cardiovascular causes) was significantly lower in the semaglutide group (331 versus 410 first events
For patients experiencing mild dyspepsia or heartburn related to Wegovy, the protective coating action of Pepto-Bismol may provide symptomatic relief
In clinical research, medicines in these classes have been associated with meaningful weight loss and improved blood sugar control in people with overweight or obesity, including those with type 2 diabetes
Ask your doctor what you should be keeping track of
The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence tirzepatide response, side effect risk, and efficacy